Fathimanoud, Correspondent, India Pharma Outlook
India's pharmaceutical and healthcare industries are expanding beyond established manufacturing strengths into vaccine research, molecular diagnostics and advanced medical technologies.
Women leaders are increasingly contributing to this transition, combining business leadership with scientific innovation and healthcare entrepreneurship.
From strengthening pharmaceutical operations to developing faster infection-detection tools, their work reflects the growing diversity of India's healthcare innovation ecosystem.
Leena Gandhi Tewari of USV, Suchitra Ella of Bharat Biotech, Varsha Shridhar of Molecular Solutions Care Health, Geethanjali Radhakrishnan of Adiuvo Diagnostics and Janani Venkatraman of Biomoneta Research represent five distinct contributors to this evolving landscape.
As Chairperson of USV Private Limited, Leena Gandhi Tewari represents an established pharmaceutical enterprise with a strong presence in diabetes and cardiovascular care.
Her leadership comes at a time when pharmaceutical companies must balance established therapeutic businesses with changing healthcare demands, research investments and evolving market opportunities.
USV's portfolio in chronic disease management reflects the importance of sustained pharmaceutical capabilities in addressing India's growing burden of non-communicable diseases.
Tewari's position also highlights the role of long-term leadership in maintaining pharmaceutical businesses through changing industry conditions. Beyond commercial priorities, USV's healthcare initiatives and social commitments reflect the broader responsibilities of pharmaceutical companies in improving patient access and outcomes. Her contribution underscores how experienced leadership remains central to India's pharmaceutical growth and healthcare delivery.
Also Read: Moving Indian Pharma from Volume to Value Through Innovation and Strategic Partnerships
Suchitra Ella, Co-founder and Managing Director of Bharat Biotech International Limited, has helped build one of India's prominent vaccine development and manufacturing enterprises.
Founded in 1996, Bharat Biotech has developed a strong presence in innovative vaccines and biotechnology, contributing to India's capabilities in addressing infectious diseases.
Its development of Covaxin during the COVID-19 pandemic brought particular attention to domestic vaccine research and manufacturing.
Suchitra's responsibilities extend across business development, finance, customer operations and company management, complementing the organization’s scientific capabilities. Her leadership also reaches beyond the company through industry engagement.
In 2026, she became President-Designate of the Confederation of Indian Industry for 2026–27, reflecting her expanding role in India's industrial leadership. Her journey illustrates how biotechnology entrepreneurship can strengthen domestic innovation while supporting broader industry development.
Varsha Shridhar, associated with Molecular Solutions Care Health LLP, represents the growing importance of molecular diagnostics in India's healthcare system.
The Bengaluru-based organization works across molecular testing, infectious diseases, real-time PCR, point-of-care diagnostics and public-health laboratory services. These capabilities support disease detection and testing across multiple healthcare settings, including community-based programs.
Molecular diagnostics provides a greater precision in identifying infections and monitoring diseases, making them increasingly relevant to clinical care and public-health preparedness.
Shridhar's work in this space reflects the need to connect advanced diagnostic capabilities with accessible healthcare services.
As India strengthens its disease surveillance and testing infrastructure, organizations working in molecular diagnostics can help bridge gaps between laboratory innovation and practical healthcare delivery.
“I wanted to be more than just a lab scientist – I wanted to be a public health problem-solver. I started Molecular Solutions Care Health with a motto of ‘Access to all’. Over the past ten years, I have worked to facilitate timely and accurate diagnostics for tuberculosis and maternal health, while contributing to infectious disease diagnostics. The larger vision that drives me is a world where anyone in need of health services gets them at the right time and price,” says Varsha Shridhar, Director, Co-founder, and Chief Enabling Officer (CEO) of Molecular Solutions Care Health LLP.
Also Read: Why Global Pharma is Moving to India: The 2026 India CDMO Boom and Market Outlook
Geethanjali Radhakrishnan,
Founder and Managing Director of Adiuvo Diagnostics, is advancing wound assessment through imaging-based diagnostic technology.
The company's flagship product, Illuminate, uses multispectral autofluorescence imaging and machine learning to detect and classify pathogens associated with wound infections.
The technology can screen wounds non-invasively and generate results in approximately two minutes, compared with the several days often required for conventional culture-based testing.
This approach has particular relevance to diabetic foot ulcers and other difficult-to-heal wounds, where delayed infection identification can complicate treatment.
Faster screening can help clinicians assess infections, guide wound management and support more targeted treatment decisions. Radhakrishnan's work demonstrates how optical technologies and artificial intelligence can address practical clinical challenges while creating new possibilities for point-of-care diagnostics.
Janani Venkatraman, Co-founder and leader associated with Biomoneta Research, represents India's emerging deep-tech efforts in infection prevention.
The Bengaluru-based company develops biological contamination management technologies, with a particular focus on airborne microbial control in healthcare environments.
Its ZeBox technology powers Avata Rx, a medical air-cleaning device designed to actively capture and neutralize airborne microorganisms.
Biomoneta received USFDA 510(k) Class II clearance for Avata Rx in 2025, marking an important regulatory milestone for its medical technology.
The development highlights the growing relevance of engineering-led solutions in hospital infection prevention, particularly where airborne contamination presents risks to patients and healthcare professionals. Venkatraman's entrepreneurial journey reflects the potential of deep-tech innovation to complement conventional infection-control practices and strengthen patient safety.
These five leaders represent different but interconnected dimensions of India's healthcare progress. Their contributions span pharmaceutical leadership, vaccine development, molecular diagnostics, infection screening and prevention.
Together, they illustrate how women's leadership is helping expand India's innovation capabilities beyond traditional pharmaceutical manufacturing. As research, technology and healthcare delivery increasingly converge, their work reflects the opportunities for women-led leadership to shape the country's next phase of healthcare development.
Fathimanoud is a Correspondent with experience covering the manufacturing and pharmaceutical sectors. She has written several articles on the pharma and manufacturing industries, with a particular focus on pharmaceutical developments and industry updates.
Published on: 16-11-2026